Beta-catenin

Clinical trials for Beta-catenin explained in plain language.

Never miss a new study

Get alerted when new Beta-catenin trials appear

Sign up with your email to follow new studies for Beta-catenin, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet recruiting 1

New drug FOG-001 takes on Hard-to-Treat cancers

Disease control Recruiting now

This early-phase trial is testing a new drug, FOG-001, in about 595 people with advanced or metastatic solid tumors, including colorectal, prostate, and liver cancers. The drug is given alone or with other cancer treatments to see if it is safe and shrinks tumors. The study is cu…

Matched conditions: BETA-CATENIN

Phase 1/2 • Sponsor: Parabilis Medicines, Inc. • Aim: Disease control

Last updated Aug 19, 2026 00:00 UTC

Beta-catenin

Get alerted when new Beta-catenin trials appear

New drug FOG-001 takes on Hard-to-Treat cancers